4.6 Review

The epigenetic effects of butyrate: potential therapeutic implications for clinical practice

Journal

CLINICAL EPIGENETICS
Volume 4, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1868-7083-4-4

Keywords

epigenome; histone deacetylase inhibitor; short chain fatty acids

Funding

  1. AIFA [FARM6FJ728]

Ask authors/readers for more resources

Butyrate is a short chain fatty acid derived from the microbial fermentation of dietary fibers in the colon. In the last decade, multiple beneficial effects of butyrate at intestinal and extraintestinal level have been demonstrated. The mechanisms of action of butyrate are different and many of these involve an epigenetic regulation of gene expression through the inhibition of histone deacetylase. There is a growing interest in butyrate because its impact on epigenetic mechanisms will lead to more specific and efficacious therapeutic strategies for the prevention and treatment of different diseases ranging from genetic/metabolic conditions to neurological degenerative disorders. This review is focused on recent data regarding the epigenetic effects of butyrate with potential clinical implications in human medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available